Note: You are reading this message either because your browser is not standards-compliant, or your browser failed to load our css files.

Newsletter
May 6, 2007
Volume VIII, Issue 32
Home Page : www.otcjournal.com
Email Questions or Comments To: editor@otcjournal.com

To OTC Journal Members:
 

Comments in the BLOG

I've posted several new BLOGS in the past week for your review. Early in the week I posted some commentary on the nice surge in EFSF on news of the double digit growth in Cinnergen sales. You'll find thoughts on a good entry point for a pullback. Secondly, there are some observations on schizophrenic under achiever CPNE, which I believe is ripe for a big surge. Thirdly, some comments on TTGL which got whacked earlier this week. The stock traded down to my SSL and rebounded.

The BLOG is your opportunity to ask questions and offer comments. I will make an effort to answer every legitimate question. If I don't know the answer, I will contact the management and get the answer. Alternatively, if you have questions you don't want publicly displayed, you can always email me directly at editor@otcjournal.com.

To use the BLOG, simply go to the home page at www.otcjournal.com - the BLOG scrolls down from the upper right hand corner. The most current journal entries appear on the right hand side of you screen. Check back frequently for updates particularly when stocks are moving to overbought or oversold levels in volatile markets.
 

Microcap Malaise: When Will it Change?

One loyal reader, Jeff K, asks for a current explanation of the "State of the Micro Cap" market in the BLOG last week. As I was thinking about that very subject, let's address it this weekend. Always happy to oblige whenever possible. 

The market is now having a long overdue love affair with large caps stocks, and the small stocks seem to be all but forgotten for the time being.

We enjoyed outstanding market conditions for the small stocks from September to the end of January. In February the inevitable correction arrived and most of the microcaps gave back 30% to 40% of their breathtaking gains.

In April the larger stocks started to power higher, and the talking heads on CNBC were absolutely giddy reporting the DOW's move through 13,000, while the S&P 500 and the NASDAQ Comp made new 6 year highs. The market is absolutely in love with large caps right now, and the micros have all but fallen off the radar screen. We've already corrected, so we're not seeing big sell offs, but volume has dried up to next to nothing, and stocks simply are not moving.

Is the broader market really blasting ahead of the microcaps? Instead of just surmising, let's look at the facts. Here's a comparative chart I put together to give us hard evidence of what's really happening. It features three micros that have done very well for OTC Journal members. I'm sure there are some examples of microcaps powering higher right now, but I can't cover all 4,000 of them.

In green you see a chart of EFSF. In blue you see a chart of PNWIF. In yellow you see CPNE. All big wins unless you are a really inept trader. Over laid on those three OTC Journal microcaps is a chart of the S&P 500 in red- the real measure of the large cap market. The DOW is only symbolic.

All these stocks and the S&P 500 made big moves since the summer of '06. Just after we turn the corner in '07, there is significant correction in all the charts. All four come down quite significantly in February.

However, look what happens in March. The S&P 500 powers to a new high, while the three microcaps extend out sideways with some herky jerky action.

The premise proves out- for the time being these three micros are dead on the screen vs the large cap stocks.

This phenomenon is known as "Divergence". The S&P is breaking away, while the micros are just sitting there. So- here's the main question and the theme of today's edition- what's causing this and where to from here? All divergences eventually correct- do we see the larger market collapse? Or do the micros perk up and start to chase their grandfathers?

I believe there are several factors fueling the "Micro Malaise" right now. First, the market is obsessed with large cap stocks, simply taking the attention away from the smaller stocks. The media loves a large cap rally.

Secondly, there is the seasonal factor. Investors have memories, and last year anything you bought in May got hammered in June and July. Of course, the Israelis and Hezbollah were lobbing rockets back and forth over the Lebanese border, and oil spiked dramatically. Conditions are different this year- while oil is still high, it is not spiking in dramatic fashion. If it did, it would allow the Bears to get the media focused on the "R" and "I" words (recession and inflation).

I believe (barring any international geo-political crises) this year will be different. It is the market's job to constantly confuse and confound us. If you're expecting a repeat of last June and July, the market will probably confound you and move considerably higher. Right now, we have inflation running at 2 1/2%, while GDP is running at about 2%. We are getting close to the point where the FED can start to lower interest rates and stimulate the economy. Lower interest rates are good for stocks. 

So, when will the micros come back into favor? At this point in time, would you rather own the S&P 500? - after all, the rally is getting a bit extended- it is a shaggy and scruffy rally that could use a makeover. Conversely, would you rather load up on your favorite microcaps? They have recently enjoyed a makeover; they are clean cut, fresh from a trimming, and fundamentally looking quite good.

I realize one is high risk- the other much lower risk, so you should be investing different kinds of capital. However, this divergence will not continue forever. As the large cap rally extends, the market will start looking at the smaller names which haven't moved for a while. 

We have lower volumes and extended sideways trading. The longer it goes on, the bigger the moves will be when they happen. Look for a rally to begin soon.
 

Subscribe

Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription. Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Subscribe Here

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.

Disclaimer
The OTCjournal.com Newsletter is an independent electronic publication committed to providing our readers with factual information on selected  publicly traded companies. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward  maximizing the upside potential for investors while minimizing the downside risk, whenever possible.  Moreover, as detailed below, this publication accepts compensation from certain of the companies which it features.  Likewise, this newsletter is owned by MarketByte, LLC.  To the degrees enumerated herein,  this newsletter should not be regarded as an independent publication.

Go Here to view our compensation on every company we have ever covered, or visit the following web address:  http://www.otcjournal.com/disclaimer.html for our full profiles and http://www.otcjournal.com/trading-alerts/disclaimer.html for Trading Alerts.

All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities  mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

From time to time MarketByte LLC sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.

The editor, members of the editor's family, and/or entities with which they are affiliated aside from MarketBtye LLC itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter. Some of the companies featured in the OTC Journal pay a cash ESP fee to an affiliated technology company ranging from $2,000 to $5,000 per month for internet related technology services.

The Trustee of the MarketByte LLC Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested approximately The Trustee of the MarketByte LLC Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested approximately $310,0000 in the Longview Fund (“the Longview Limited Partnership”), a limited partnership in which the MarketByte Pension Plan is a limited partner. No one associated with the MarketByte Pension Plan has any knowledge, information, or control as to any past, present, or future investment activities of the Longview Fund.  Longview ocassoinally refers companies to MarketByte LLC for possible coverage by one of the MarketByte LLC publications, which publications include The OTCJournal.com Newsletter. Longview may or may not own shares in the companies that it so refers to MarketByte. MarketByte has no information (outside of information readily accessible to the general public such as SEC filings) as to whether Longview owns any shares in the companies that it refers to MarketByte LLC.  The above relationships should be viewed as a potential and/or actual conflict of interest by shareholders and prospective shareholders of MarketByte LLC client companies. 

The profiles, critiques, and other editorial content of the OTCjournal.com may contain statements that appear foward relating to the expected capabilities of the companies mentioned herein.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN  SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN  CONSENT OF THE EDITORS OF OTCjournal.com.

We encourage our readers to invest carefully and read the investor information available at the web sites of  the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at  http://www.sec.gov/consumer/cyberfr.htm. Disclaimer ID:$subst('Recip.userid') Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.  MarketByte LLC's mailing address is 4653 Carmel Mtn Rd Suite 308 #402, San Diego, CA 92130.


Unsubscribe Here

You can unsubscribe from this list at any time by Clicking Here and HITTING SEND. If you are having difficulty removing yourself or wish to change your address please go to http://listserv.otcjournal.com/opt.cgi?.

 

Click Here to View the OTC Journal Disclosure

China Energy Recovery, Inc.
Newsletter
Editions
RSS Subscribe

To subscribe to our newsletter, please enter your email address below.

FROG Poised To Bounce
January 24, 2012

Share
Market Summary
Nasdaq 2903.88 -23.35 (-0.80%)
Russell 2K 813.33 +0.00 (+0.00%)
S&P 500 1342.64 -9.31 (-0.69%)
S&P 100 607.12 -3.98 (-0.65%)
Quotes are delayed 20 minutes.

Add to Google

China Stocks and Penny Stocks - Discover Tomorrow's Winners Today

© 2012 OTC Journal